Assessment of Comorbidity as a Risk Factor for Edematous Pancreatitis Considering IL-4 (C-590T) Gene Polymorphism

The comorbidities affect the course of pancreatitis significantly; however, this effect has not been evaluated from the perspective of genetic component.The objective of the research was to analyse concomitant chronic diseases as potential risk factors for edematous pancreatitis considering genetic...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivashchuk, Serge Ivanovich (Author), Sydorchuk, Larysa Petrivna (Author)
Format: EJournal Article
Published: Ivano-Frankivsk National Medical University, 2017-03-23.
Subjects:
Online Access:Get Fulltext
Get Fulltext
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02876 am a22003133u 4500
001 galician_E2017112_687
042 |a dc 
100 1 0 |a Ivashchuk, Serge Ivanovich  |e author 
700 1 0 |a Sydorchuk, Larysa Petrivna  |e author 
245 0 0 |a Assessment of Comorbidity as a Risk Factor for Edematous Pancreatitis Considering IL-4 (C-590T) Gene Polymorphism 
260 |b Ivano-Frankivsk National Medical University,   |c 2017-03-23. 
500 |a https://ifnmujournal.com/gmj/article/view/E2017112 
520 |a The comorbidities affect the course of pancreatitis significantly; however, this effect has not been evaluated from the perspective of genetic component.The objective of the research was to analyse concomitant chronic diseases as potential risk factors for edematous pancreatitis considering genetic predictors.Materials and methods. The epidemiological analysis of comorbidities (cholelithiasis, urolithiasis, ischemic heart disease, past viral infection) as risk factors for edematous pancreatitis was performed. Polymorphic variants of the IL-4 (rs 2243250) gene being identified in 123 patients and 40 healthy individuals were also involved.Results. In patients with edematous pancreatitis, urolithiasis was observed more frequently than in the control group - by 37.30% (χ2=18.62, p<0.001). The presence of cholelithiasis insignificantly increases the risk of edematous pancreatitis in the future (RR-1.156; 95% CI: 0.972-1.374). The presence of urolithiasis increased the risk of edematous pancreatitis twofold (RR-2.039; 95% CI: 1.346-3.090; p<0.05).Conclusions. 1. Cholelithiasis increases the probability of developing edematous pancreatitis in carriers of the mutant T-allele of the IL-4 gene by 3.7 times (RR=3.69; OR=10.13; 95% CI OR: 3.17-32.42; p<0.05). 2. In the C-allele carriers of the IL-4 (C-590T) gene, the risk of developing acute pancreatitis is twice higher in the presence of urolithiasis or ischemic heart disease, and almost five times higher in case of past viral infection (p<0.05). 
540 |a Copyright (c) 2017 Serge Ivanovich Ivashchuk, Larysa Petrivna Sydorchuk 
540 |a https://creativecommons.org/licenses/by-nc/4.0 
546 |a eng 
690 |a gene 
690 |a polymorphism 
690 |a IL-4 
690 |a comorbidities 
655 7 |a info:eu-repo/semantics/article  |2 local 
655 7 |a info:eu-repo/semantics/publishedVersion  |2 local 
786 0 |n Galician Medical Journal; Vol. 24 No. 1 (2017); E2017112 
786 0 |n Galician Medical Journal; Том 24 № 1 (2017); E2017112 
786 0 |n 2414-1518 
787 0 |n https://ifnmujournal.com/gmj/article/view/E2017112/E2017112PDF 
787 0 |n https://ifnmujournal.com/gmj/article/view/E2017112/687 
856 4 1 |u https://ifnmujournal.com/gmj/article/view/E2017112/E2017112PDF  |z Get Fulltext 
856 4 1 |u https://ifnmujournal.com/gmj/article/view/E2017112/687  |z Get Fulltext